November 2020

NEWS & COLUMNS

6-7 NEWS
Bayer pays an initial $2bn for AskBio; EMA reviewing Biogen's potential Alzheimer's drug

8-11 CORONAVIRUS NEWS
UK invests in human challenge trials for COVID-19; FDA approves Gilead's remdesivir

12 DARWIN'S MEDICINE
The chief executive ostrich – some of the most perplexing executive behaviour is simply Darwinian

13 POLICY AND PUBLIC HEALTH
Be careful what you wish for – ten months into this pandemic, it seems a lot of people are hoping for some strange things

14 WINTER IS COMING
The importance of looking after our mental and physical health while working from home

15 LAUNCH LEADERS' BLOG
How can launch leaders innovate?

FEATURES

16-17 RETHINKING INFECTIOUS
DISEASE PREPAREDNESS
The importance of long-term strategic investment to prepare for the next threat that emerges

18-19 THE IMPORTANT ROLE OF CLINICAL RESEARCH ORGANISATIONS
Looking at the impact of COVID-19 on clinical research activities and the resulting acceleration of innovation across many areas

20-21 BIOSIMILARS IN THE US MARKET
The US celebrates five years of biosimilars on the market – a look to the past, present and future

23 DIGITISING HEALTHCARE
The market for IoT in healthcare is projected to reach $534bn by 2025.

24-25 DIGITAL HEALTHCARE 
AND CHRONIC DISEASES
With approximately half of all adults worldwide living with a chronic condition, providers are looking at digital solutions to transform this area of healthcare